HALBT is being developed as a focused technology business with single-cell protein at the core of its identity, strategy, and long-term value. The company is advancing novel SCP systems designed to bring biological innovation, process thinking, and practical application together in a clear and commercially relevant way.
HALBT’s position is built on more than protein alone. The company is developing a broader innovation capability around microbial systems, production logic, and enabling technologies that support future-facing biological production. This gives HALBT a stronger platform for growth, differentiation, and long-term strategic relevance.
The HALBT SCP Program is the company’s primary development focus and central innovation pathway. It is built around the advancement of novel microbial protein technologies with strong relevance to future feed systems and broader bio-based production opportunities.
A key direction within this program is the development of an innovative MOB-HOB cascading SCP production system. This reflects HALBT’s commitment to original technology thinking, differentiated system design, and the creation of meaningful value within the emerging SCP sector.
The HALBT SCP Program is where the company’s scientific direction, innovation effort, and commercial ambition come together most clearly.
HALBT is building more than a single concept. The company is developing an innovation platform around SCP technologies, biological systems, production architecture, and application-led technical development.
This platform approach strengthens HALBT’s long-term relevance by connecting scientific depth with practical market direction. It allows the company to build differentiated technology pathways that are technically credible, commercially meaningful, and aligned with the changing needs of future production industries.
Focused on differentiated microbial protein technologies with clear strategic direction.
HALBT is positioned to engage with organisations that recognise the long-term importance of innovative protein systems and enabling biological technologies. The company welcomes discussion with aligned commercial parties, research groups, strategic collaborators, and other stakeholders interested in meaningful engagement around its SCP direction.
With a focused technology identity and a clear development pathway, HALBT offers a strong foundation for collaboration where innovation, scientific capability, and future market relevance intersect.
Whether you are exploring collaboration, partnership, or the HALBT technology platform more broadly, we welcome the opportunity to connect.